GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » PB Ratio

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) PB Ratio : 1.09 (As of Apr. 25, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-25), Aspen Pharmacare Holdings's share price is $11.29. Aspen Pharmacare Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $10.34. Hence, Aspen Pharmacare Holdings's PB Ratio of today is 1.09.

The historical rank and industry rank for Aspen Pharmacare Holdings's PB Ratio or its related term are showing as below:

APNHY' s PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.66   Max: 6.93
Current: 1.1

During the past 13 years, Aspen Pharmacare Holdings's highest PB Ratio was 6.93. The lowest was 0.58. And the median was 1.66.

APNHY's PB Ratio is ranked better than
74.12% of 962 companies
in the Drug Manufacturers industry
Industry Median: 1.945 vs APNHY: 1.10

During the past 12 months, Aspen Pharmacare Holdings's average Book Value Per Share Growth Rate was 13.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 8.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 13.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Aspen Pharmacare Holdings was 53.70% per year. The lowest was 8.50% per year. And the median was 25.75% per year.

Back to Basics: PB Ratio


Aspen Pharmacare Holdings PB Ratio Historical Data

The historical data trend for Aspen Pharmacare Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings PB Ratio Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.87 0.92 1.10 0.89 0.94

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 0.89 0.82 0.94 1.06

Competitive Comparison of Aspen Pharmacare Holdings's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's PB Ratio falls into.



Aspen Pharmacare Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Aspen Pharmacare Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=11.29/10.34
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Aspen Pharmacare Holdings  (OTCPK:APNHY) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Aspen Pharmacare Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019